Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Cellular response to small molecules that selectively stall protein synthesis by the ribosome

Nadège Liaud, Max A. Horlbeck, Luke A. Gilbert, Ketrin Gjoni, Jonathan S. Weissman, Jamie H. D. Cate
doi: https://doi.org/10.1101/461624
Nadège Liaud
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max A. Horlbeck
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA
3Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94158, USA
4California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94158, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke A. Gilbert
5Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA
6Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ketrin Gjoni
7Department of Chemistry, University of California, Berkeley, Berkeley, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan S. Weissman
2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA
3Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94158, USA
4California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, CA 94158, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie H. D. Cate
1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA
7Department of Chemistry, University of California, Berkeley, Berkeley, California, USA
8QB3 Institute, University of California, Berkeley, Berkeley, California, USA
9Molecular Biophysics and Integrated Bio-imaging, Lawrence Berkeley National Laboratory, Berkeley, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

ABSTRACT

Identifying small molecules that inhibit protein synthesis by selectively stalling the ribosome constitutes a new strategy for therapeutic development. Compounds that inhibit the translation of PCSK9, a major regulator of low-density lipoprotein cholesterol, have been identified that reduce LDL cholesterol in preclinical models and that affect the translation of only a few off-target proteins. Although some of these compounds hold potential for future therapeutic development, it is not known how they impact the physiology of cells or ribosome quality control pathways. Here we used a genome-wide CRISPRi screen to identify proteins and pathways that modulate cell growth in the presence of high doses of a selective PCSK9 translational inhibitor, PF-06378503 (PF8503). The two most potent genetic modifiers of cell fitness in the presence of PF8503, the ubiquitin binding protein ASCC2 and helicase ASCC3, bind to the ribosome and protect cells from toxic effects of high concentrations of the compound. Surprisingly, translation quality control proteins Pelota (PELO) and HBS1L sensitize cells to PF8503 treatment. In genetic interaction experiments, ASCC3 acts together with ASCC2, and functions downstream of HBS1L. Taken together, these results identify new connections between ribosome quality control pathways, and provide new insights into the selectivity of compounds that stall human translation that will aid the development of next-generation selective translation stalling compounds to treat disease.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 04, 2018.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cellular response to small molecules that selectively stall protein synthesis by the ribosome
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cellular response to small molecules that selectively stall protein synthesis by the ribosome
Nadège Liaud, Max A. Horlbeck, Luke A. Gilbert, Ketrin Gjoni, Jonathan S. Weissman, Jamie H. D. Cate
bioRxiv 461624; doi: https://doi.org/10.1101/461624
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cellular response to small molecules that selectively stall protein synthesis by the ribosome
Nadège Liaud, Max A. Horlbeck, Luke A. Gilbert, Ketrin Gjoni, Jonathan S. Weissman, Jamie H. D. Cate
bioRxiv 461624; doi: https://doi.org/10.1101/461624

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Systems Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4654)
  • Biochemistry (10299)
  • Bioengineering (7614)
  • Bioinformatics (26189)
  • Biophysics (13446)
  • Cancer Biology (10620)
  • Cell Biology (15333)
  • Clinical Trials (138)
  • Developmental Biology (8452)
  • Ecology (12754)
  • Epidemiology (2067)
  • Evolutionary Biology (16763)
  • Genetics (11356)
  • Genomics (15400)
  • Immunology (10548)
  • Microbiology (25041)
  • Molecular Biology (10152)
  • Neuroscience (54096)
  • Paleontology (398)
  • Pathology (1655)
  • Pharmacology and Toxicology (2877)
  • Physiology (4314)
  • Plant Biology (9196)
  • Scientific Communication and Education (1579)
  • Synthetic Biology (2541)
  • Systems Biology (6752)
  • Zoology (1452)